Deal Description

Oncodynamix has two revenue lines. 1. The precision medicine platform uses advanced Ai-driven technology to predict the clinical response of a cancer patient to which drug or combination of drugs will work best for this individual’s cancer. Key benefits include: * Personalized approach to each patient * Improved clinical outcomes and longer survival * Quick screening to help in drug response treatment * Avoids drug reactions/toxicity-patient sufferingUtilized proprietary gene panels to increase the accuracy of the treatment chosen 2. Our Ai-driven platform is used by drug development teams for cancer drug discovery. The process more quickly identifies fundamental answers to questions (e.g., in which cancer cell lines and patient populations will a particular drug or compound show enhanced therapeutic effects). Key benefits include: * Reducing the cost of R & D significantly * Improves successful outcome of drugs * Reducing the length of time in clinical trials * Faster screening of SOC drugs or pan cancer drugs which helps in drug response treatment

No Files Attached